Loading clinical trials...
Loading clinical trials...
A Phase 1 Pilot Safety and Feasibility Study of Muscle Progenitor Cell (MPC) Therapy for Urinary Incontinence
Conditions
Interventions
Autologous Muscle Progenitor Cells
Locations
2
United States
Wake Forest Urology Clinic
Winston-Salem, North Carolina, United States
Wake Forest Institute for Regenerative Medicine (WFIRM)
Winston-Salem, North Carolina, United States
Start Date
January 1, 2014
Primary Completion Date
January 1, 2018
Completion Date
January 1, 2018
Last Updated
March 1, 2024
NCT05362292
NCT07105150
NCT01953263
NCT06411158
NCT06706362
NCT05806164
Lead Sponsor
Wake Forest University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions